Literature DB >> 27903799

CXCR6-Mediated Simian Immunodeficiency Virus SIVagmSab Entry into Sabaeus African Green Monkey Lymphocytes Implicates Widespread Use of Non-CCR5 Pathways in Natural Host Infections.

Katherine S Wetzel1, Yanjie Yi1, Sarah T C Elliott1, Dino Romero1, Beatrice Jacquelin2, Beatrice H Hahn1, Michaela Muller-Trutwin2, Cristian Apetrei3, Ivona Pandrea3, Ronald G Collman4.   

Abstract

African green monkeys (AGM) and sooty mangabeys (SM) are well-studied natural hosts of simian immunodeficiency virus (SIV) that do not progress to AIDS when infected with their species-specific viruses. Natural hosts of SIV express very low levels of the canonical entry coreceptor CCR5, and recent studies have shown that CCR5 is dispensable for SIV infection of SM in vivo and that blocking of CCR5 does not prevent ex vivo infection of peripheral blood mononuclear cells (PBMC) from SM or vervet AGM. In both hosts, CXCR6 is an efficient entry pathway in vitro Here we investigated the use of species-matched CXCR6 and other alternative coreceptors by SIVagmSab, which infects sabaeus AGM. We cloned sabaeus CD4 and 10 candidate coreceptors. Species-matched CXCR6, CCR5, and GPR15 mediated robust entry into transfected cells by pseudotypes carrying SIVagmSab92018ivTF Env, with lower-level entry through GPR1 and APJ. We cloned genetically divergent env genes from the plasma of two wild-infected sabaeus AGM and found similar patterns of coreceptor use. Titration experiments showed that CXCR6 and CCR5 were more efficient than other coreceptors when tested at limiting CD4/coreceptor levels. Finally, blocking of CXCR6 with its ligand CXCL16 significantly inhibited SIVagmSab replication in sabaeus PBMC and had a greater impact than did the CCR5 blocker maraviroc, confirming the use of CXCR6 in primary lymphocyte infection. These data suggest a new paradigm for SIV infection of natural host species, whereby a shared outcome of virus-host coevolution is the use of CXCR6 or other alternative coreceptors for entry, which may direct SIV toward CD4+ T cell subsets and anatomical sites that support viral replication without disrupting immune homeostasis and function. IMPORTANCE: Natural hosts of SIV do not progress to AIDS, in stark contrast to pathogenic human immunodeficiency virus type 1 (HIV-1)-human and SIVmac-macaque infections. Identifying how natural hosts avoid immunodeficiency can elucidate key mechanisms of pathogenesis. It is known that despite high viral loads, natural hosts have a low frequency of CD4+ cells expressing the SIV coreceptor CCR5. In this study, we demonstrate the efficient use of the coreceptor CXCR6 by SIVagmSab to infect sabaeus African green monkey lymphocytes. In conjunction with studies of SIVsmm, which infects sooty mangabeys, and SIVagmVer, which infects vervet monkeys, our data suggest a unifying model whereby in natural hosts, in which the CCR5 expression level is low, the use of CXCR6 or other coreceptors to mediate infection may target SIV toward distinct cell populations that are able to support high-level viral replication without causing a loss of CD4+ T cell homeostasis and lymphoid tissue damage that lead to AIDS in HIV-1 and SIVmac infections.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  African green monkey; CXCR6; coreceptor; natural host; simian immunodeficiency virus; tropism

Mesh:

Substances:

Year:  2017        PMID: 27903799      PMCID: PMC5286873          DOI: 10.1128/JVI.01626-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  80 in total

1.  The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression.

Authors:  Kevin Raehtz; Ivona Pandrea; Cristian Apetrei
Journal:  Infect Genet Evol       Date:  2016-07-06       Impact factor: 3.342

2.  Expression cloning of new receptors used by simian and human immunodeficiency viruses.

Authors:  H K Deng; D Unutmaz; V N KewalRamani; D R Littman
Journal:  Nature       Date:  1997-07-17       Impact factor: 49.962

3.  Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease.

Authors:  S R Broussard; S I Staprans; R White; E M Whitehead; M B Feinberg; J S Allan
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

4.  High levels of viral replication during primary simian immunodeficiency virus SIVagm infection are rapidly and strongly controlled in African green monkeys.

Authors:  O M Diop; A Gueye; M Dias-Tavares; C Kornfeld; A Faye; P Ave; M Huerre; S Corbet; F Barre-Sinoussi; M C Müller-Trutwin
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

5.  Frequent substitution polymorphisms in African green monkey CCR5 cluster at critical sites for infections by simian immunodeficiency virus SIVagm, implying ancient virus-host coevolution.

Authors:  S E Kuhmann; N Madani; O M Diop; E J Platt; J Morvan; M C Müller-Trutwin; F Barré-Sinoussi; D Kabat
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

6.  Co-receptor usage of BOB/GPR15 in addition to CCR5 has no significant effect on replication of simian immunodeficiency virus in vivo.

Authors:  S Pöhlmann; N Stolte; J Münch; P Ten Haaft; J L Heeney; C Stahl-Hennig; F Kirchhoff
Journal:  J Infect Dis       Date:  1999-11       Impact factor: 5.226

7.  Simian Immunodeficiency Virus SIVagm Efficiently Utilizes Non-CCR5 Entry Pathways in African Green Monkey Lymphocytes: Potential Role for GPR15 and CXCR6 as Viral Coreceptors.

Authors:  Nadeene E Riddick; Fan Wu; Kenta Matsuda; Sonya Whitted; Ilnour Ourmanov; Simoy Goldstein; Robert M Goeken; Ronald J Plishka; Alicia Buckler-White; Jason M Brenchley; Vanessa M Hirsch
Journal:  J Virol       Date:  2015-12-09       Impact factor: 5.103

8.  Damaged intestinal epithelial integrity linked to microbial translocation in pathogenic simian immunodeficiency virus infections.

Authors:  Jacob D Estes; Levelle D Harris; Nichole R Klatt; Brian Tabb; Stefania Pittaluga; Mirko Paiardini; G Robin Barclay; Jeremy Smedley; Rhonda Pung; Kenneth M Oliveira; Vanessa M Hirsch; Guido Silvestri; Daniel C Douek; Christopher J Miller; Ashley T Haase; Jeffrey Lifson; Jason M Brenchley
Journal:  PLoS Pathog       Date:  2010-08-19       Impact factor: 6.823

9.  Acute loss of intestinal CD4+ T cells is not predictive of simian immunodeficiency virus virulence.

Authors:  Ivona V Pandrea; Rajeev Gautam; Ruy M Ribeiro; Jason M Brenchley; Isolde F Butler; Melissa Pattison; Terri Rasmussen; Preston A Marx; Guido Silvestri; Andrew A Lackner; Alan S Perelson; Daniel C Douek; Ronald S Veazey; Cristian Apetrei
Journal:  J Immunol       Date:  2007-09-01       Impact factor: 5.422

10.  Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study.

Authors:  M Dean; M Carrington; C Winkler; G A Huttley; M W Smith; R Allikmets; J J Goedert; S P Buchbinder; E Vittinghoff; E Gomperts; S Donfield; D Vlahov; R Kaslow; A Saah; C Rinaldo; R Detels; S J O'Brien
Journal:  Science       Date:  1996-09-27       Impact factor: 47.728

View more
  16 in total

1.  CXCR6 gene characterization in two ethnically distinct South African populations and association with viraemic disease control in HIV-1-infected black South African individuals.

Authors:  Anabela C P Picton; Maria Paximadis; Richard E Chaisson; Neil A Martinson; Caroline T Tiemessen
Journal:  Clin Immunol       Date:  2017-04-18       Impact factor: 3.969

2.  Marginal Effects of Systemic CCR5 Blockade with Maraviroc on Oral Simian Immunodeficiency Virus Transmission to Infant Macaques.

Authors:  Egidio Brocca-Cofano; Cuiling Xu; Katherine S Wetzel; Mackenzie L Cottrell; Benjamin B Policicchio; Kevin D Raehtz; Dongzhu Ma; Tammy Dunsmore; George S Haret-Richter; Karam Musaitif; Brandon F Keele; Angela D Kashuba; Ronald G Collman; Ivona Pandrea; Cristian Apetrei
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

3.  Nonhuman Primate Models and Understanding the Pathogenesis of HIV Infection and AIDS.

Authors:  Ronald S Veazey; Andrew A Lackner
Journal:  ILAR J       Date:  2017-12-01

4.  Unique Phenotypic Characteristics of Recently Transmitted HIV-1 Subtype C Envelope Glycoprotein gp120: Use of CXCR6 Coreceptor by Transmitted Founder Viruses.

Authors:  Manickam Ashokkumar; Shambhu G Aralaguppe; Srikanth P Tripathy; Luke Elizabeth Hanna; Ujjwal Neogi
Journal:  J Virol       Date:  2018-04-13       Impact factor: 5.103

5.  Methamphetamine Dysregulates Macrophage Functions and Autophagy to Mediate HIV Neuropathogenesis.

Authors:  John M Barbaro; Simone Sidoli; Ana Maria Cuervo; Joan W Berman
Journal:  Biomedicines       Date:  2022-05-27

Review 6.  So Pathogenic or So What?-A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research.

Authors:  Adam J Kleinman; Ivona Pandrea; Cristian Apetrei
Journal:  Viruses       Date:  2022-01-12       Impact factor: 5.048

7.  CXCR7/ACKR3-targeting ligands interfere with X7 HIV-1 and HIV-2 entry and replication in human host cells.

Authors:  Thomas D'huys; Sandra Claes; Tom Van Loy; Dominique Schols
Journal:  Heliyon       Date:  2018-03-01

8.  Loss of CXCR6 coreceptor usage characterizes pathogenic lentiviruses.

Authors:  Katherine S Wetzel; Yanjie Yi; Anjana Yadav; Anya M Bauer; Ezekiel A Bello; Dino C Romero; Frederic Bibollet-Ruche; Beatrice H Hahn; Mirko Paiardini; Guido Silvestri; Martine Peeters; Ronald G Collman
Journal:  PLoS Pathog       Date:  2018-04-16       Impact factor: 6.823

Review 9.  Lymph Node Cellular and Viral Dynamics in Natural Hosts and Impact for HIV Cure Strategies.

Authors:  Nicolas Huot; Steven E Bosinger; Mirko Paiardini; R Keith Reeves; Michaela Müller-Trutwin
Journal:  Front Immunol       Date:  2018-04-19       Impact factor: 7.561

10.  African green monkeys avoid SIV disease progression by preventing intestinal dysfunction and maintaining mucosal barrier integrity.

Authors:  Kevin D Raehtz; Fredrik Barrenäs; Cuiling Xu; Kathleen Busman-Sahay; Audrey Valentine; Lynn Law; Dongzhu Ma; Benjamin B Policicchio; Viskam Wijewardana; Egidio Brocca-Cofano; Anita Trichel; Michael Gale; Brandon F Keele; Jacob D Estes; Cristian Apetrei; Ivona Pandrea
Journal:  PLoS Pathog       Date:  2020-03-02       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.